JP6352588B2 - 希少ではない細胞を用いて希少細胞を検出する方法 - Google Patents

希少ではない細胞を用いて希少細胞を検出する方法 Download PDF

Info

Publication number
JP6352588B2
JP6352588B2 JP2012535345A JP2012535345A JP6352588B2 JP 6352588 B2 JP6352588 B2 JP 6352588B2 JP 2012535345 A JP2012535345 A JP 2012535345A JP 2012535345 A JP2012535345 A JP 2012535345A JP 6352588 B2 JP6352588 B2 JP 6352588B2
Authority
JP
Japan
Prior art keywords
ctc
cells
cell
marker
rare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012535345A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013508729A5 (https=
JP2013508729A (ja
Inventor
ピーター クーン
ピーター クーン
アナンド コラトカー
アナンド コラトカー
ジョシュア クンケン
ジョシュア クンケン
デナ マリヌッチ
デナ マリヌッチ
シン ヤン
シン ヤン
ジョン アール． シュティルプナーゲル
ジョン アール． シュティルプナーゲル
Original Assignee
ザ スクリプス リサーチ インスティテュート
ザ スクリプス リサーチ インスティテュート
エピック サイエンシズ インコーポレイテッド
エピック サイエンシズ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ スクリプス リサーチ インスティテュート, ザ スクリプス リサーチ インスティテュート, エピック サイエンシズ インコーポレイテッド, エピック サイエンシズ インコーポレイテッド filed Critical ザ スクリプス リサーチ インスティテュート
Publication of JP2013508729A publication Critical patent/JP2013508729A/ja
Publication of JP2013508729A5 publication Critical patent/JP2013508729A5/ja
Application granted granted Critical
Publication of JP6352588B2 publication Critical patent/JP6352588B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hospice & Palliative Care (AREA)
  • Image Processing (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2012535345A 2009-10-21 2010-10-20 希少ではない細胞を用いて希少細胞を検出する方法 Active JP6352588B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25378709P 2009-10-21 2009-10-21
US61/253,787 2009-10-21
PCT/US2010/053431 WO2011050103A1 (en) 2009-10-21 2010-10-20 Method of using non-rare cells to detect rare cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016193236A Division JP2017053860A (ja) 2009-10-21 2016-09-30 希少ではない細胞を用いて希少細胞を検出する方法

Publications (3)

Publication Number Publication Date
JP2013508729A JP2013508729A (ja) 2013-03-07
JP2013508729A5 JP2013508729A5 (https=) 2017-08-10
JP6352588B2 true JP6352588B2 (ja) 2018-07-04

Family

ID=43900673

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012535345A Active JP6352588B2 (ja) 2009-10-21 2010-10-20 希少ではない細胞を用いて希少細胞を検出する方法
JP2016193236A Pending JP2017053860A (ja) 2009-10-21 2016-09-30 希少ではない細胞を用いて希少細胞を検出する方法
JP2018145154A Pending JP2018185339A (ja) 2009-10-21 2018-08-01 希少ではない細胞を用いて希少細胞を検出する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016193236A Pending JP2017053860A (ja) 2009-10-21 2016-09-30 希少ではない細胞を用いて希少細胞を検出する方法
JP2018145154A Pending JP2018185339A (ja) 2009-10-21 2018-08-01 希少ではない細胞を用いて希少細胞を検出する方法

Country Status (8)

Country Link
US (4) US20120276555A1 (https=)
EP (3) EP2491395B1 (https=)
JP (3) JP6352588B2 (https=)
CN (3) CN102782498A (https=)
AU (4) AU2010310688A1 (https=)
CA (1) CA2778328C (https=)
ES (2) ES2661735T3 (https=)
WO (1) WO2011050103A1 (https=)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011050103A1 (en) 2009-10-21 2011-04-28 The Scripps Research Institute Method of using non-rare cells to detect rare cells
WO2011108454A1 (ja) * 2010-03-05 2011-09-09 コニカミノルタホールディングス株式会社 細胞の検出方法及び細胞検出システム
JP5916991B2 (ja) * 2010-11-09 2016-05-11 オリンパス株式会社 遺伝子異常細胞の解析方法
BR112014000329A2 (pt) * 2011-07-07 2017-02-07 Scripps Health método de análise de distúrbios cardiovasculares e uso do mesmo
US10813630B2 (en) 2011-08-09 2020-10-27 Corquest Medical, Inc. Closure system for atrial wall
US10314594B2 (en) 2012-12-14 2019-06-11 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
US10307167B2 (en) 2012-12-14 2019-06-04 Corquest Medical, Inc. Assembly and method for left atrial appendage occlusion
WO2013109944A1 (en) * 2012-01-18 2013-07-25 The Trustees Of The University Of Pennsylvania Methods for assessing risk for cancer using biomarkers
KR101716555B1 (ko) 2012-01-24 2017-03-14 화이자 인코포레이티드 포유동물 대상체에서 5t4-양성 순환 종양 세포를 검출하는 방법 및 5t4-양성 암을 진단하는 방법
US20140142689A1 (en) 2012-11-21 2014-05-22 Didier De Canniere Device and method of treating heart valve malfunction
HK1218784A1 (zh) * 2013-03-11 2017-03-10 罗氏血液诊断公司 對血細胞進行成像
WO2014143981A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Deposition and imaging of particles on planar substrates
US10115034B2 (en) * 2013-05-01 2018-10-30 Life Technologies Holdings Pte Limited Method and system for projecting image with differing exposure times
US10225483B1 (en) * 2013-05-01 2019-03-05 Pierce Biotechnology, Inc. Method and system for projecting image with differing exposure times
JP6453592B2 (ja) * 2013-09-25 2019-01-16 アークレイ株式会社 血液検体の処理方法
WO2015048740A1 (en) 2013-09-30 2015-04-02 The Scripps Research Institute Genotypic and phenotypic analysis of circulating tumor cells to monitor tumor evolution in prostate cancer patients
EP3683321B1 (en) * 2013-10-21 2021-12-08 The General Hospital Corporation Methods relating to circulating tumor cell clusters and the treatment of cancer
US9566443B2 (en) 2013-11-26 2017-02-14 Corquest Medical, Inc. System for treating heart valve malfunction including mitral regurgitation
WO2015088979A1 (en) * 2013-12-09 2015-06-18 The Scripps Research Institute Methods for the detection and quantification of circulating endothelial cells
EP3083979B1 (en) 2013-12-19 2019-02-20 Axon DX, LLC Cell detection, capture and isolation methods and apparatus
WO2015112960A1 (en) * 2014-01-27 2015-07-30 Epic Sciences, Inc. Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
US20160011198A1 (en) * 2014-01-27 2016-01-14 Epic Sciences, Inc. Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
US10527624B2 (en) * 2014-01-27 2020-01-07 Epic Sciences, Inc. Circulating tumor cell diagnostics for prostate cancer biomarkers
US20150212089A1 (en) * 2014-01-30 2015-07-30 Epic Sciences, Inc. Circulating tumor cell diagnostics for biomarkers predictive of resistance to androgen receptor (ar) targeted therapies
EP3100053B1 (en) * 2014-01-31 2021-09-08 Epic Sciences, Inc. Methods for the detection and quantification of circulating tumor cell mimics
EP3108246B1 (en) 2014-02-21 2019-10-09 Epic Sciences, Inc. Methods for analyzing rare circulating cells
EA201692223A1 (ru) 2014-05-09 2017-04-28 Дзе Скриппс Рисерч Инститьют Композиции и способы жидкостной биопсии меланомы
CN107250796B (zh) * 2014-09-25 2020-10-23 艾匹克科学公司 用于鉴别对雄激素受体靶向疗法的抵抗性的循环肿瘤细胞诊断
WO2016049658A1 (en) * 2014-09-26 2016-03-31 The Regents Of The University Of California Method of assessing disease condition of cancer
US10842626B2 (en) 2014-12-09 2020-11-24 Didier De Canniere Intracardiac device to correct mitral regurgitation
US20180017568A1 (en) * 2015-01-29 2018-01-18 Konica Minolta, Inc. Method for simultaneously analyzing blood cells having interactive molecules
ES3007999T3 (en) * 2015-04-21 2025-03-21 Genentech Inc Compositions and methods for prostate cancer analysis
US20180155794A1 (en) * 2015-05-29 2018-06-07 Epic Sciences, Inc. Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) associated to phenotypic ctc heterogeneity in metastatic castrate resistant prostate cancer (mcrpc)
WO2017079212A1 (en) * 2015-11-04 2017-05-11 Axon Dx, Llc Cell detection, capture, analysis, aggregation, and output methods and apparatus
WO2017126634A1 (ja) * 2016-01-19 2017-07-27 東ソー株式会社 希少細胞を用いて癌患者の予後を予測する方法
US9739783B1 (en) * 2016-03-15 2017-08-22 Anixa Diagnostics Corporation Convolutional neural networks for cancer diagnosis
US10360499B2 (en) 2017-02-28 2019-07-23 Anixa Diagnostics Corporation Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis
US9934364B1 (en) 2017-02-28 2018-04-03 Anixa Diagnostics Corporation Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis
US11164082B2 (en) 2017-02-28 2021-11-02 Anixa Diagnostics Corporation Methods for using artificial neural network analysis on flow cytometry data for cancer diagnosis
CN108646034B (zh) * 2018-07-03 2020-10-23 珠海圣美生物诊断技术有限公司 细胞群中的稀有细胞判读方法
CN111079579B (zh) * 2019-12-02 2023-07-25 英华达（上海）科技有限公司 细胞图像的识别方法、装置以及系统
KR102929382B1 (ko) 2020-07-17 2026-02-20 주식회사 엘지에너지솔루션 고로딩 전극을 위한 집전체용 시트의 압연 방법 및 고로딩 전극
EP4123577A4 (en) * 2020-07-30 2024-04-03 Hamamatsu Photonics K.K. Assessment device, assessment method, assessment program, and recording medium
CN113567672A (zh) * 2021-07-26 2021-10-29 江南大学附属医院 一种检测腹水或腹腔灌洗液中癌细胞的试剂盒
EP4445141A1 (en) * 2021-12-07 2024-10-16 Epic Sciences, Inc. Enhanced characterization of breast cancer
CN114910455B (zh) * 2022-05-06 2025-06-20 马海燕 一种稀有单细胞识别轮廓的可视化的方法

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9233698A (en) 1997-11-22 1999-06-17 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer cells and/or hematologic progenitor cells in whole blood
US6197523B1 (en) 1997-11-24 2001-03-06 Robert A. Levine Method for the detection, identification, enumeration and confirmation of circulating cancer and/or hematologic progenitor cells in whole blood
US20010018058A1 (en) 1997-12-24 2001-08-30 Reed Steven G. Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
US8192994B2 (en) 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
BR9907852A (pt) 1998-02-12 2000-10-24 Immunivest Corp Processos para detectar e enumerar células raras e cancerosas em uma população celular mista, para diagnosticar câncer de estágio precoce em um paciente de teste, para determinar a probabilidade de recorrência de câncer em um paciente humano anteriormente tratado de câncer, para distinguir um carcinoma confinado ao órgão de um carcinoma com propriedades metastáticas, para acompanhar a situação de remissão em um paciente humano com câncer que passa pelo tratamento de terapia contra o câncer e para aumentar quantidades de células epiteliais circulantes em uma amostra de sangue, partìcula magnética revestida, composição, conjuntos de teste para avaliar uma amostra de paciente quanto a presença de células raras circulantes, quanto a presença de células de tumor circulantes, quanto a presença de células de câncer de mama circulantes, quanto a presença de células de câncer de próstata circulantes, quanto a presença de células de câncer de cólon circulantes, quanto a presença de células de câncer de bexiga circulantes e para monitorar um paciente quanto a recorrência de câncer, e, fração de sangue periférico enriquecido quanto a células neoplásticas circulantes
JP2002514762A (ja) 1998-05-09 2002-05-21 アイコニシス，インコーポレーテッド コンピュータによって制御された、胎児細胞を含む希少細胞に基づく診断のための方法および装置
US6960449B2 (en) 1999-02-10 2005-11-01 Cell Works Diagnostics, Inc. Class characterization of circulating cancer cells isolated from body fluids and methods of use
US7546210B2 (en) * 2000-06-08 2009-06-09 The Regents Of The University Of California Visual-servoing optical microscopy
AU6674801A (en) * 2000-06-08 2001-12-17 Univ California Visual-servoing optical microscopy
US7033832B2 (en) 2000-10-13 2006-04-25 University Of Medicine And Dentistry Of New Jersey Endothelial cell—cell cohesion
AU2002249481A1 (en) 2000-10-25 2002-08-12 Exiqon A/S Open substrate platforms suitable for analysis of biomolecules
US6701197B2 (en) 2000-11-08 2004-03-02 Orbotech Ltd. System and method for side to side registration in a printed circuit imager
EP1322957B1 (en) 2001-05-04 2009-08-12 Biosite Incorporated Diagnostic markers of acute coronary syndromes and methods of use thereof
US20080009019A1 (en) * 2001-06-13 2008-01-10 Smithkline Beecham Corporation High throughput method for screening candidate compounds for biological activity
US7863012B2 (en) 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
WO2003019141A2 (en) * 2001-08-23 2003-03-06 Immunivest Corporation Analysis of circulating tumor cells, fragments, and debris
US7943093B2 (en) 2001-12-12 2011-05-17 Erie Scientific Company Cover slip
CA2474509C (en) * 2002-02-14 2012-01-31 Immunivest Corporation Methods and algorithms for cell enumeration in a low-cost cytometer
US7305112B2 (en) 2002-10-15 2007-12-04 The Scripps Research Institute Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media
US7113624B2 (en) 2002-10-15 2006-09-26 Palo Alto Research Center Incorporated Imaging apparatus and method employing a large linear aperture
US7282180B2 (en) * 2003-07-02 2007-10-16 Immunivest Corporation Devices and methods to image objects
US7372985B2 (en) * 2003-08-15 2008-05-13 Massachusetts Institute Of Technology Systems and methods for volumetric tissue scanning microscopy
WO2005100999A2 (en) * 2004-04-08 2005-10-27 Cornell Research Foundation, Inc. Functional immunohistochemical cell cycle analysis as a prognostic indicator for cancer
WO2006041453A1 (en) 2004-09-30 2006-04-20 Immunivest Corporation Circulating tumor cells (ctc’s): apoptotic assessment in prostate cancer patients
EP1825317B1 (en) * 2004-11-24 2013-04-17 Battelle Memorial Institute Optical system for cell imaging
US7280261B2 (en) 2004-12-20 2007-10-09 Palo Alto Research Center Incorporated Method of scanning and light collection for a rare cell detector
US20090081688A1 (en) * 2005-06-20 2009-03-26 Advanced Cell Diagnostics Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
US20070009389A1 (en) 2005-07-08 2007-01-11 Antti Seppo Slide deposition chamber
US9134237B2 (en) 2005-09-20 2015-09-15 Janssen Diagnotics, LLC High sensitivity multiparameter method for rare event analysis in a biological sample
ES2420834T3 (es) * 2006-01-30 2013-08-27 The Scripps Research Institute Métodos de detección de células tumorales circulantes y métodos de diagnóstico del cáncer en un sujeto mamífero
WO2011050103A1 (en) 2009-10-21 2011-04-28 The Scripps Research Institute Method of using non-rare cells to detect rare cells
US8337755B2 (en) * 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
US20080076727A1 (en) 2006-03-29 2008-03-27 John Wayne Cancer Institute Utility of high molecular weight melanoma associated antigen in diagnosis and treatment of cancer
US20090105963A1 (en) * 2006-05-13 2009-04-23 Jesper Laursen Methods for Flow Cytometry Analyses of Un-Lysed Cells from Biological Fluids
NZ573187A (en) * 2006-06-02 2011-11-25 Pfizer Prod Inc Circulating tumor cell assay for predicting efficacy of 1gf-1r antagonist therapy
US20080090239A1 (en) * 2006-06-14 2008-04-17 Daniel Shoemaker Rare cell analysis using sample splitting and dna tags
EP2041299A4 (en) * 2006-07-14 2010-01-13 Aviva Biosciences Corp METHOD AND COMPOSITIONS FOR DETECTION OF RARE CELLS FROM A BIOLOGICAL SAMPLE
US20080113358A1 (en) * 2006-07-28 2008-05-15 Ravi Kapur Selection of cells using biomarkers
JP5548890B2 (ja) * 2006-09-05 2014-07-16 ジャンセン ダイアグノスティックス，エルエルシー 細胞の画像を格付けするための方法
US8244021B2 (en) 2006-12-20 2012-08-14 Ventana Medical Systems, Inc. Quantitative, multispectral image analysis of tissue specimens stained with quantum dots
CN101226118B (zh) 2007-01-19 2010-06-16 中国医学科学院肿瘤研究所 一种兼容免疫荧光分析的细胞化学染色方法及其用途
US20100184629A1 (en) 2007-06-05 2010-07-22 Nanopoint, Inc. Cell tray systems and methods
EP2201134B1 (en) 2007-09-19 2018-11-21 The Research Foundation of State University of New York Gene expression signatures in enriched tumor cell samples
WO2009051734A1 (en) * 2007-10-17 2009-04-23 The General Hospital Corporation Microchip-based devices for capturing circulating tumor cells and methods of their use
WO2009064933A2 (en) 2007-11-13 2009-05-22 Ikonisys, Inc. Detection of circulating tumor cells in peripheral blood with an automated scanning fluorescence microscope
US20090258365A1 (en) 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
US20110189670A1 (en) 2008-07-07 2011-08-04 Ruth L Katz Circulating Tumor and Tumor Stem Cell Detection Using Genomic Specific Probes
US9779213B2 (en) 2008-07-25 2017-10-03 Fundacao D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud System for evaluating a pathological stage of prostate cancer
US8324280B2 (en) 2008-08-07 2012-12-04 The University Of British Columbia Treatment of prostate cancer with DDC inhibitor
WO2010028160A1 (en) 2008-09-05 2010-03-11 The Scripps Research Institute Methods for the detection of circulating tumor cells
WO2011093927A1 (en) 2010-01-27 2011-08-04 Duke University Biomarkers for circulating tumor cells
US20130130241A1 (en) 2010-03-08 2013-05-23 Regents Of The University Of Minnesota Androgen receptor isoforms and methods
TWI539158B (zh) 2010-06-08 2016-06-21 維里德克斯有限責任公司 使用血液中之循環黑色素瘤細胞預測黑色素瘤病患之臨床結果的方法。
EP2625292B1 (en) 2010-10-07 2018-12-05 The General Hospital Corporation Biomarkers of cancer
KR102759126B1 (ko) 2010-12-30 2025-01-24 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
AU2012209329A1 (en) 2011-01-24 2013-09-12 Epic Sciences, Inc. Methods for obtaining single cells and applications of single cell omics
BR112014000329A2 (pt) 2011-07-07 2017-02-07 Scripps Health método de análise de distúrbios cardiovasculares e uso do mesmo
US20130078667A1 (en) 2011-09-22 2013-03-28 Oscar B. Goodman Methods for detecting and collecting circulating tumor cells
WO2013049926A1 (en) 2011-10-06 2013-04-11 UNIVERSITé LAVAL PROGNOSTIC MARKERS OF INHERITED VARIATIONS IN THE 17β-HYDROXYSTEROID DEHYDROGENASE (HSD17B) GENES FOR PROSTATE CANCER
CA2858689A1 (en) 2011-12-09 2013-06-13 The Scripps Research Institute Apparatus, system and method for identifying circulating tumor cells
US20130171642A1 (en) 2011-12-30 2013-07-04 Ventana Medical Systems, Inc. Automated analysis of circulating tumor cells
KR101716555B1 (ko) 2012-01-24 2017-03-14 화이자 인코포레이티드 포유동물 대상체에서 5t4-양성 순환 종양 세포를 검출하는 방법 및 5t4-양성 암을 진단하는 방법
AU2013267253B2 (en) 2012-06-01 2018-03-29 Creatv Microtech, Inc. Capture, identification and use of a new biomarker of solid tumors in body fluids
WO2014008155A1 (en) 2012-07-02 2014-01-09 The General Hospital Corporation Diagnosis and monitoring treatment of prostate cancer
US20140024024A1 (en) 2012-07-17 2014-01-23 General Electric Company Methods of detecting dna, rna and protein in biological samples
WO2014047285A1 (en) 2012-09-19 2014-03-27 Paraskevi Giannakakou Identifying taxane sensitivity in prostate cancer patients
CA2889765C (en) 2012-10-26 2021-06-22 Minna D. BALBAS Androgen receptor variants and methods for making and using
WO2014120265A1 (en) 2013-02-02 2014-08-07 Duke University Method of isolating circulating tumor cells
BR112015023120A2 (pt) 2013-03-15 2017-11-21 Genentech Inc método para identificar um indivíduo com uma doença ou disfunção, método para prever a responsividade de um indivíduo com uma doença ou disfunção, método para determinar a probabilidade de que um indivíduo com uma doença ou disfunção exibirá benefício do tratamento, método para selecionar uma terapia, usos de um antagonista de ligação do eixo pd-l1, ensaio para identificar um indivíduo com uma doença, kit de diagnóstico, método para avaliar uma resposta ao tratamento e método para monitorar a resposta de um indivíduo tratado
WO2015048740A1 (en) 2013-09-30 2015-04-02 The Scripps Research Institute Genotypic and phenotypic analysis of circulating tumor cells to monitor tumor evolution in prostate cancer patients
US20150147339A1 (en) 2013-11-15 2015-05-28 Psma Development Company, Llc Biomarkers for psma targeted therapy for prostate cancer
US20170192003A1 (en) 2013-12-03 2017-07-06 The Scripps Research Institute Compositions and methods for fluid biopsy of melanoma
EP3702785A1 (en) 2013-12-30 2020-09-02 The Scripps Research Institute Circulating tumor cell diagnostics for lung cancer
US20160011198A1 (en) 2014-01-27 2016-01-14 Epic Sciences, Inc. Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
WO2015112960A1 (en) 2014-01-27 2015-07-30 Epic Sciences, Inc. Circulating tumor cell diagnostics for detection of neuroendocrine prostate cancer (nepc)
US10527624B2 (en) 2014-01-27 2020-01-07 Epic Sciences, Inc. Circulating tumor cell diagnostics for prostate cancer biomarkers
US20150212089A1 (en) 2014-01-30 2015-07-30 Epic Sciences, Inc. Circulating tumor cell diagnostics for biomarkers predictive of resistance to androgen receptor (ar) targeted therapies
EP3100053B1 (en) 2014-01-31 2021-09-08 Epic Sciences, Inc. Methods for the detection and quantification of circulating tumor cell mimics
EP3108246B1 (en) 2014-02-21 2019-10-09 Epic Sciences, Inc. Methods for analyzing rare circulating cells
CN107250796B (zh) 2014-09-25 2020-10-23 艾匹克科学公司 用于鉴别对雄激素受体靶向疗法的抵抗性的循环肿瘤细胞诊断
EP3207377B1 (en) 2014-10-15 2024-11-06 Epic Sciences, Inc. Circulating tumor cell diagnostics for therapy targeting pd-l1
US20180155794A1 (en) 2015-05-29 2018-06-07 Epic Sciences, Inc. Intra-patient genomic heterogeneity of single circulating tumor cells (ctcs) associated to phenotypic ctc heterogeneity in metastatic castrate resistant prostate cancer (mcrpc)
EP3371327B1 (en) 2015-11-03 2024-12-18 Epic Sciences, Inc. Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity
US20190025312A1 (en) 2016-01-06 2019-01-24 Epic Sciences, Inc. Single cell genomic profiling of circulating tumor cells (ctcs) in metastatic disease to characterize disease heterogeneity

Also Published As

Publication number Publication date
EP3045918B1 (en) 2017-12-06
US20120276555A1 (en) 2012-11-01
US20210033612A1 (en) 2021-02-04
EP3045918A1 (en) 2016-07-20
EP3385716A2 (en) 2018-10-10
US20190257834A1 (en) 2019-08-22
CN107422127A (zh) 2017-12-01
AU2021202220A1 (en) 2021-05-06
WO2011050103A1 (en) 2011-04-28
ES2556639T3 (es) 2016-01-19
ES2661735T3 (es) 2018-04-03
JP2017053860A (ja) 2017-03-16
EP2491395A1 (en) 2012-08-29
JP2018185339A (ja) 2018-11-22
CN102782498A (zh) 2012-11-14
CA2778328C (en) 2018-12-18
CN115060882A (zh) 2022-09-16
AU2016203462B2 (en) 2018-07-12
AU2010310688A1 (en) 2012-05-17
JP2013508729A (ja) 2013-03-07
EP3385716A3 (en) 2019-01-09
AU2016203462A1 (en) 2016-06-09
US20180100857A1 (en) 2018-04-12
EP2491395A4 (en) 2013-05-22
AU2018247290A1 (en) 2018-11-01
EP2491395B1 (en) 2015-09-16
CA2778328A1 (en) 2011-04-28
US10613089B2 (en) 2020-04-07

Similar Documents

Publication Publication Date Title
JP6352588B2 (ja) 希少ではない細胞を用いて希少細胞を検出する方法
US20230085158A1 (en) Method of using non-rare cells to detect rare cells
US20140329917A1 (en) Apparatus, system and method for identifying circulating tumor cells
JP5479355B2 (ja) 血液中の循環黒色腫細胞の自動計数及び特徴付け
JP5889883B2 (ja) 血液中の循環黒色腫細胞を使用して黒色腫患者の臨床成果を予測する方法。
JP6109464B2 (ja) 生体サンプル中の希有な事象の分析のための高感度マルチパラメータ法
US20080113350A1 (en) Blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (FISH)
CN102482703A (zh) 对循环肿瘤细胞进行分类的方法
JP2008533487A (ja) 循環腫瘍細胞を用いる転移性乳癌患者の療法中の各追跡期間ポイントでの無増悪および全生存を予測する方法
WO2005116264A2 (en) A blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (fish)
EP3924733B1 (en) Ccr5-based methods for predicting overall and progression free survival in subjects having cancer

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131017

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140612

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140723

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141021

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141028

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150121

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150122

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150511

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150520

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150611

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150909

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151209

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160602

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161110

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20161125

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20170113

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170621

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20170621

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180405

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180607

R150 Certificate of patent or registration of utility model

Ref document number: 6352588

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250